Karyopharm Therapeutics | SC TO-C: Written communication relating to an issuer or third party tender offer
Apr 8 17:13 ET
Karyopharm Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 8 16:43 ET
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.
Apr 5 17:24 ET
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.
Mar 6 16:18 ET
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rangwala Reshma
Mar 4 19:46 ET
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Poulton Stuart
Mar 4 19:41 ET
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mason Michael
Mar 4 19:41 ET
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mano Michael
Mar 4 19:41 ET
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cheng Sohanya Roshan
Mar 4 19:41 ET
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.
Mar 4 19:41 ET
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mano Michael
Feb 29 17:40 ET
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mason Michael
Feb 29 17:40 ET
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Poulton Stuart
Feb 29 17:40 ET
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rangwala Reshma
Feb 29 17:39 ET
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cheng Sohanya Roshan
Feb 29 17:39 ET
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.
Feb 29 17:39 ET
Karyopharm Therapeutics | 10-K: Annual report
Feb 29 07:48 ET
Karyopharm Therapeutics | 8-K: Current report
Feb 29 07:38 ET
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Poulton Stuart
Feb 20 17:05 ET
Karyopharm Therapeutics | 8-K: Current report
Feb 20 08:03 ET
No Data
No Data